Results

Total Results: over 10,000 records

Showing results for "months".

  1. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/40182/psn-pdf
    September 25, 2011 - Using a data-matrix–coded sponge counting system across a surgical practice: impact after 18 months. … Using a data-matrix-coded sponge counting system across a surgical practice: impact after 18 months.
  2. digital.ahrq.gov/ahrq-funded-projects/home-heart-failure-hf-care-comparing-patient-driven-technology-models/annual-summary/2008
    January 01, 2008 - testing the technology, this pilot required pushing the timetable for the HF study out by at least 6 months … related to participant enrollment at all sites necessitated an abbreviated data collection period of 9 months … of active participation plus 3 months of followup monitoring. … Patient enrollment concluded in May 2007; active study participation thus concluded in March 2008, with 3 months
  3. digital.ahrq.gov/ahrq-funded-projects/using-health-information-technology-improve-health-care-quality-primary-care-va/annual-summary/2012
    January 01, 2012 - Impact and Findings: Within 6 months, an average of 14.4 percent (ranging from 1.5 to 28.3 percent) … the study period all six practices had varying rates of utilization ranging from 0.8 percent over 9 months … in one practice to 22.2 percent over 15 months in another. … cancer screening, cholesterol screening, and tetanus vaccinations for IPHR users compared to non-users 4 months
  4. digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/rollman-bl-et-al-2002
    January 01, 2002 - Rating Scale for Depression (HRS-D) score and chart review of PCP reports of depression care in the 6 months … Only 22% of patients recovered from their depressive episode at 6 months (HRS-D less than or equal to7 … treatment advice (e.g., depression mentioned in greater than or equal to 3 contacts with usual PCP at 6 months … 18% UC; P = .09 and antidepressant medication suggested/prescribed or baseline regimen modified at 6 months
  5. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/38307/psn-pdf
    January 07, 2009 - English and Welsh hospitals: a national observational study based on retrospective analysis of 12 months … English and Welsh hospitals: a national observational study based on retrospective analysis of 12 months
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
    January 01, 2010 - At 30-months, DES patients had lower unadjusted rates of death (12.9% vs. 17.9%), MI (7.3 vs. 10.0/ … The DES survival benefit was observed in all subgroups analyzed and persisted throughout 30- months’ … The adjusted mortality difference was statistically significant in the initial six months post-PCI, … This result was driven by lower MI rates in DES patients during the first 12-months post-PCI (Figure … 2b), with no difference between 12 and 30-months of follow-up.
  7. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary2/healthy-diet-and-physical-activity-counseling-adults-with-high-risk-of-cvd-august-2014
    August 26, 2014 - , intermediate term was 12 to 24 months, and long term was greater than 24 months). … (IQR, 4 to 11 months). … (IQR, 8 to 18 months). … limited trials reporting follow-up beyond 24 months. … (median, 12 months duration [IQR, 6 to 12 months]).
  8. effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
    January 01, 2012 - Fifty-foot walk pain improved 47% and 70% from baseline at 6 and 12 months, respectively. … declining at 12 months’ followup (p=0.02). … At 3 months, patients taking placebo who were not responding were given tofacitinib. … At 6 months, all placebo-assigned patients were advanced to tofacitinib. … Placebo patients were given tofacitinib at 3 months.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
    October 01, 2016 - DHA, DHA+EPA, DHA+AA), follow-up time (i.e. birth, 12 months of age), and population (i.e. pregnant … on VEP at 4 months (WMD -0.06 [-0.12, 0.01]; I2=1.7%) and 6 months corrected age (WMD -0.04[ -0.09 … At 4 months follow- up, the pooled effect size for behavioral measurements was significant in favor … The pooled difference in MDI scores at 18 months was not significant when 3 RCTs were pooled. … but not at 2 months, when assessed using VEP.
  10. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/35130/psn-pdf
    March 11, 2011 - Investigators studied the likelihood of inappropriate prescribing 4 months before and 14 months after
  11. digital.ahrq.gov/sites/default/files/docs/publication/r21hs018238-eaton-final-report-2012.pdf
    January 01, 2012 - After 3 additional months the remaining patients that only received [HBPM + PHR + web portal] at 3 months … Primary outcomes Measures Baseline 3 months 6 months 9 months Blood Pressure RV1 RV2 RV3 RV4 Clinical … Secondary outcomes Measures Baseline 3 months 6 months 9 months Health Status (SF-12) RV1 RV2 RV3 … Confounder/mediators Measures Baseline 3 months 6 months 9 months Charlson co-morbidity index (Chart … Process of care Measures Baseline 3 months 6 months 9 months Pattern of utilization (Chart Audits,
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/o8MbPkZcdMh7McJu4-UCVu
    September 01, 2015 - This final recommendation statement applies to children ages 6 months to 2 years old who do not have … Being born early or with low birth weight • Not having iron-rich foods added to their diet after 6 months … studies to help them understand if routine screening would improve these outcomes in children ages 6 months … assess the balance of benefits and harms of screening for iron deficiency anemia in children 6 to 24 months … For example, this recommendation applies only to infants and children ages 6 months to 2 years old.
  13. hcup-us.ahrq.gov/db/vars/dxn/nrdnote.jsp
    August 01, 2015 - In the data prior to 1998, a six months window (three months before and three months after) is allowed … Beginning in the 1998 data, a year window (six months before and six months after) is allowed.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pqmp-protocol.pdf
    April 01, 2014 - Developmental screening is recommended in infancy (at 9 months) and early childhood (at 18 and 30 months … ), with screening for autism spectrum disorder in early childhood (at 18 and 24 months). … Perform risk assessment with appropriate action to follow if positive (at 4, 6, and 9 months) … (at 18 and 30 months) --- --- Autism Spectrum Disorder Screening --- Perform AUTISM SCREEN (at … 18 and 24 months) --- --- Evidence-based Practice Center Technical Brief Protocol Project
  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
    July 01, 2009 - Key Question 1.What is the effect of RFA on short-term (6 to 12 months) and long-term (>12 months) rhythm … evidence showing no statistically significant difference in the risk of cerebrovascular events at 12 months … This study of patients with PAF found no significant difference at 12 months followup in the recurrence … The only exception was the diagnosis of PV stenosis, which was routinely screened for at around 3 months … In addition, followup durations longer than the typical 6 to 12 months observed in the current literature
  16. digital.ahrq.gov/sites/default/files/docs/citation/r18hs017046-krist-final-report-2011.pdf
    January 01, 2011 - , and 16-months post initial invitation to use the IPHR. … post-intervention), and March 2009 (16-months post-intervention). … At baseline, 4-months, and 16-months post-intervention, we determined the percentage of all eligible … We then calculated the incremental change between baseline and 4-months and baseline and 16-months ( … Increases were observed at 4-months and in some cases were still significant 16-months after patients
  17. digital.ahrq.gov/sites/default/files/docs/citation/r18hs018932-hess-final-report-2015.pdf
    January 01, 2015 - Patients answered detailed questions about their health behaviors and HRQoL at baseline, 6, and 12 months … , and 12-months 2. … At baseline, 12-months, and 24-months, physician participants completed information regarding self-efficacy … , HRQoL, self-efficacy, and referrals Baseline 6-months 12-months 70 30 * … Activity 6 Months [median (IQR)] 1 (-5, 15) 2 (-2, 13) 0.70 12 Months [median (IQR)] 1 (-4, 10) -2.37
  18. digital.ahrq.gov/sites/default/files/docs/page/THQITStoriesWeissman2010.pdf
    December 31, 2007 - to use the e­ prescribing software at no cost, a free hand­held device to run the software, and 6 months … research team tracked the prescribing patterns of participating and nonparticipating physicians from 6 months … before the e­ prescribing system was in place through 12 months after it was implemented.
  19. digital.ahrq.gov/sites/default/files/docs/publication/r01hs017939-carroll-final-report-2013.pdf
    January 01, 2013 - for developmental delay significantly increased the numbers of children screened at 9, 18, and 30 months … Participants Patients younger than 66 months of age were automatically placed into either the control … Over 6,000 of these kids received ASQs for routine developmental screening – 1,199 at 9 months old; … 1,166 at 18 months old, and 3,819 at 24 through 36 months. … These charts could be any visit not occurring in the 9, 18, and 30 months visits.
  20. cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
    January 01, 2003 - • Adjuvant analgesic medication recorded on meds list within last six months Risk Factors display … ) - STarT Back (within past 6 months) Risk Screening: - GAD-7 (within past 12 months) - PHQ-9 (within … (within past 12 months) - UDS resulted (within past two years) - UDS resulted (within past 6 months) … (within past 12 months) - Single Substance (SSASQ) completed (more than 12 months in the past) TESTCASE … ) - AUDIT completed (within past 12 months) - DAST completed (within past 12 months) Orders: Referral